Literature DB >> 23774769

IBD: Golimumab shows promise in treatment of active ulcerative colitis.

Katherine Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23774769     DOI： 10.1038/nrgastro.2013.108

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.

Authors:  William J Sandborn; Brian G Feagan; Colleen Marano; Hongyan Zhang; Richard Strauss; Jewel Johanns; Omoniyi J Adedokun; Cynthia Guzzo; Jean-Frederic Colombel; Walter Reinisch; Peter R Gibson; Judith Collins; Gunnar Järnerot; Toshifumi Hibi; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2013-06-02       Impact factor: 22.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.